- Home
- CHR vs AKTX Comparison
CHR vs AKTX Comparison
Compare CHR & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHR
- AKTX
- Stock Information
- Founded
- CHR 2016
- AKTX N/A
- Country
- CHR China
- AKTX United States
- Employees
- CHR N/A
- AKTX N/A
- Industry
- CHR EDP Services
- AKTX Biotechnology: Pharmaceutical Preparations
- Sector
- CHR Technology
- AKTX Health Care
- Exchange
- CHR Nasdaq
- AKTX Nasdaq
- Market Cap
- CHR 26.1M
- AKTX 29.5M
- IPO Year
- CHR N/A
- AKTX N/A
- Fundamental
- Price
- CHR $2.60
- AKTX $0.99
- Analyst Decision
- CHR
- AKTX
- Analyst Count
- CHR 0
- AKTX 0
- Target Price
- CHR N/A
- AKTX N/A
- AVG Volume (30 Days)
- CHR 261.7K
- AKTX 80.4K
- Earning Date
- CHR 07-31-2024
- AKTX 02-15-2025
- Dividend Yield
- CHR N/A
- AKTX N/A
- EPS Growth
- CHR N/A
- AKTX N/A
- EPS
- CHR 3.44
- AKTX N/A
- Revenue
- CHR $155,947,000.00
- AKTX N/A
- Revenue This Year
- CHR N/A
- AKTX N/A
- Revenue Next Year
- CHR N/A
- AKTX N/A
- P/E Ratio
- CHR $0.76
- AKTX N/A
- Revenue Growth
- CHR 0.88
- AKTX N/A
- 52 Week Low
- CHR $2.18
- AKTX $0.90
- 52 Week High
- CHR $3.90
- AKTX $4.40
- Technical
- Relative Strength Index (RSI)
- CHR 41.85
- AKTX 31.38
- Support Level
- CHR $2.69
- AKTX $0.95
- Resistance Level
- CHR $3.10
- AKTX $1.13
- Average True Range (ATR)
- CHR 0.24
- AKTX 0.15
- MACD
- CHR -0.02
- AKTX 0.02
- Stochastic Oscillator
- CHR 10.53
- AKTX 15.15
About CHR Cheer Holding Inc.
Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerReal, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).